Completed NA INTERVENTIONAL 2-arm NCT03431688

Tailored Therapy for Clarithromycin-Resistant H. Pylori

Efficacy Comparison of Metronidazole-based Triple and Bismuth-based Quadruple Therapy for Clarithromycin Resistant-Helicobacter Pylori Infection: Randomized Controlled Trial

Sponsor: Kangdong Sacred Heart Hospital

Conditions Helicobacter Pylori Infection

Interventions PAM PBMT

Updated 9 times since 2018 Last updated: Sep 17, 2025 Started: Oct 1, 2018 Primary completion: Oct 30, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Helicobacter Pylori Infection and is currently completed. Kangdong Sacred Heart Hospital leads this study, which shows 9 recorded versions since 2018 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

9 versions recorded

Oct 2025 — Present [monthly]

Completed NA

Status: Unknown → Completed
Sep 2025 — Oct 2025 [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 4 earlier versions

Jan 2021 — Oct 2021 [monthly]

Recruiting NA
Apr 2019 — Jan 2021 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2018 — Apr 2019 [monthly]

Not Yet Recruiting NA
Mar 2018 — Jun 2018 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kangdong Sacred Heart Hospital

Data source: Kangdong Sacred Heart Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea